GlucoTrack Inc (NASDAQ: GCTK) has experienced a rise in its stock price by 11.93 compared to its previous closing price of 0.55. However, the company has seen a gain of 33.98% in its stock price over the last five trading days. InvestorPlace reported 2023-04-13 that GlucoTrack (NASDAQ: GCTK ) stock is falling on Thursday after the medical device company revealed plans for a proposed public stock offering. According to a news release from the company, it’s planning for a firm commitment underwritten public offering.
Is It Worth Investing in GlucoTrack Inc (NASDAQ: GCTK) Right Now?
GCTK has 36-month beta value of 0.16.
The public float for GCTK is 17.26M, and currently, short sellers hold a 0.62% ratio of that float. The average trading volume of GCTK on May 06, 2024 was 193.34K shares.
GCTK’s Market Performance
The stock of GlucoTrack Inc (GCTK) has seen a 33.98% increase in the past week, with a 52.77% rise in the past month, and a 193.41% gain in the past quarter. The volatility ratio for the week is 13.50%, and the volatility levels for the past 30 days are at 20.95% for GCTK. The simple moving average for the past 20 days is 9.75% for GCTK’s stock, with a 112.76% simple moving average for the past 200 days.
GCTK Trading at 48.92% from the 50-Day Moving Average
After a stumble in the market that brought GCTK to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -38.38% of loss for the given period.
Volatility was left at 20.95%, however, over the last 30 days, the volatility rate increased by 13.50%, as shares surge +22.27% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +164.07% upper at present.
During the last 5 trading sessions, GCTK rose by +33.98%, which changed the moving average for the period of 200-days by +72.56% in comparison to the 20-day moving average, which settled at $0.5613. In addition, GlucoTrack Inc saw 133.27% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at GCTK starting from SYCOFF DREW, who purchase 182,540 shares at the price of $1.26 back on Apr 22 ’24. After this action, SYCOFF DREW now owns 2,951,258 shares of GlucoTrack Inc, valued at $230,000 using the latest closing price.
Stock Fundamentals for GCTK
The total capital return value is set at -0.78. Equity return is now at value -320.91, with -193.41 for asset returns.
Based on GlucoTrack Inc (GCTK), the company’s capital structure generated 0.06 points at debt to capital in total, while cash flow to debt ratio is standing at -33.46. The debt to equity ratio resting at 0.06. The interest coverage ratio of the stock is -2657.0.
Currently, EBITDA for the company is -7.09 million with net debt to EBITDA at 1.62. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.22.
Conclusion
To put it simply, GlucoTrack Inc (GCTK) has had a better performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
